GordonMD Global Investments LP

CIK

2039349

Location

Beverely Hills, CA

Portfolio Value

Small $156,929,309

Diversification

Diversified

Filing Date

Global Rank

#4,751 / 8,622 ▲ 409 · as of Mar 2026

Top Industry

Biotechnology 65.5%

3Y Alpha vs SPY

+10.2%

Period ended 4 months ago

Filed May 15, 2026 · 2mo

2 quarters · since Dec 2025

Clone Performance

Feb 2026–Jul 2026 · vs SPY

Hypothetical growth of buying every stock this filer reported holding, rebalancing on each filing and indexed to the same start. Option positions cannot be bought this way and are left out.

Cloned portfolio

+14.0%

SPY

+9.0%

Annualised alpha

+12.6%

Max drawdown

−16.5%

Estimate. 13F holdings are quarter-lagged, so the clone rebalances about 45 days after each period end — when the filing becomes public — and it excludes option and short positions. It tracks 100% of reported value on average across 2 quarters. Past performance does not predict future results.

Portfolio Concentration

16 tracked positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025

Top Position

24.1%

−5.5 pts

Top 5

66.5%

−0.8 pts

Top 10

85.3%

−4.5 pts

HHI

1,365

Diversified−88

Portfolio Trend

2 quarters · across all stocks

Sector Breakdown

As of Mar 31, 2026

Sector	% Portfolio	Value	Positions
Healthcare	100.0%	$156,929,309	16

Last Quarter's Activity

Export CSV

Mar 31, 2026 vs Dec 31, 2025

Added To

Positions the filer increased

2 positions

Ticker	Company	Δ Shares	Shares	Value
VIR	Vir Biotechnology, Inc.	+588,235	1,518,552	$13,606,225
TEVA	Teva Pharmaceutical Industries Ltd	+487,945	1,257,495	$37,875,749
No positions match the current search.

Trimmed

Positions the filer reduced

8 positions

Ticker	Company	Δ Shares	Shares	Value
TSHA	Taysha Gene Therapies, Inc.	−593,351	737,550	$3,296,848
KYTX	Kyverna Therapeutics, Inc.	−147,000	4,244,818	$36,632,779
CRNX	Crinetics Pharmaceuticals, Inc.	−97,150	126,985	$4,612,095
BLCO	Bausch & Lomb Corp	−40,000	573,472	$9,118,204
RARE	Ultragenyx Pharmaceutical Inc.	−40,000	289,101	$6,056,665
TARS	Tarsus Pharmaceuticals, Inc.	−24,000	42,680	$2,994,002
INCY	Incyte Corp	−11,200	43,300	$4,075,396
AMGN	Amgen Inc	−3,000	20,212	$7,111,592
No positions match the current search.

New Positions

Positions the filer opened this quarter

3 positions

Ticker	Company	Shares	Value
SRRK	Scholar Rock Holding Corp	132,500	$6,513,700
SION	Sionna Therapeutics, Inc.	136,000	$5,452,240
ALLO	Allogene Therapeutics, Inc.	1,430,000	$3,489,200
No positions match the current search.

Sold Out

Positions the filer fully exited

No qualifying positions this quarter.

Portfolio Positions

Compact Export CSV View 13F filing

16 tracked positions · $156,929,309 total · filing declares 16 positions · $143,592,724 · as of Mar 31, 2026

All sectors Healthcare

Ticker	Company	Type	Shares	Δ Shares	Value (USD)	% Δ Value	% of Portfolio
TEVA	Teva Pharmaceutical Industries Ltd Healthcare	Added	1,257,495	+487,945	$37,875,749	+57.7%	24.14%
KYTX	Kyverna Therapeutics, Inc. Healthcare	Reduced	4,244,818	-147,000	$36,632,779	−11.3%	23.34%
VIR	Vir Biotechnology, Inc. Healthcare	Added	1,518,552	+588,235	$13,606,225	+142.5%	8.67%
BLCO	Bausch & Lomb Corp Healthcare	Reduced	573,472	-40,000	$9,118,204	−13.0%	5.81%
AMGN	Amgen Inc Healthcare	Reduced	20,212	-3,000	$7,111,592	−6.4%	4.53%
SRRK	Scholar Rock Holding Corp Healthcare	NEW	132,500	NEW	$6,513,700	NEW	4.15%
RARE	Ultragenyx Pharmaceutical Inc. Healthcare	Reduced	289,101	-40,000	$6,056,665	−20.0%	3.86%
PYXS	Pyxis Oncology, Inc. Healthcare	Held	4,121,870	0	$6,017,930	+27.0%	3.83%
SION	Sionna Therapeutics, Inc. Healthcare	NEW	136,000	NEW	$5,452,240	NEW	3.47%
CLDX	Celldex Therapeutics, Inc. Healthcare	Held	170,307	0	$5,402,138	+16.8%	3.44%
INSM	INSMED Inc Healthcare	Held	28,587	0	$4,674,546	−6.0%	2.98%
CRNX	Crinetics Pharmaceuticals, Inc. Healthcare	Reduced	126,985	-97,150	$4,612,095	−55.8%	2.94%
INCY	Incyte Corp Healthcare	Reduced	43,300	-11,200	$4,075,396	−24.3%	2.60%
ALLO	Allogene Therapeutics, Inc. Healthcare	NEW	1,430,000	NEW	$3,489,200	NEW	2.22%
TSHA	Taysha Gene Therapies, Inc. Healthcare	Reduced	737,550	-593,351	$3,296,848	−55.0%	2.10%
TARS	Tarsus Pharmaceuticals, Inc. Healthcare	Reduced	42,680	-24,000	$2,994,002	−45.2%	1.91%

Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.